PEGCETACOPLAN
pegcetacoplan 1.08 g/20 mL injection, 20 mL vial
PEGCETACOPLAN (13180Q)
13180Q
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Initial treatment - Initial 2 (switching from a Complement 5 (C5) inhibitor)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $4,343.86 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||